John Carroll

I’ll be head­ed in­to Boston on Wednes­day for this year’s End­points 11. And this year, we have some very in­ter­est­ing plans to cel­e­brate our se­lec­tion

Astel­las is snap­ping in an­oth­er piece of the re­al es­tate puz­zle for its glob­al R&D re­or­ga­ni­za­tion. Just as it wraps one project to piece to­geth­er

A decade af­ter SQZ was birthed amid con­sid­er­able en­thu­si­asm and mid­wifed by one of the biggest sci­en­tif­ic stars in Cam­bridge, MA, the few sur­vivors of

Tes­sa Ther­a­peu­tics’ web­site has gone dark. Any­one Googling up ref­er­ences to a re­view of the pipeline, the peo­ple, its hun­dreds of mil­lions raised for can­cer

Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you

This past six months, the num­bers have start­ed to track up­ward in biotech — and we’re not just talk­ing about M&A here. We’re start­ing to

As se­nior gov­ern­ment of­fi­cials in the US war­i­ly look to sta­bi­lize rocky re­la­tions with Chi­na, one glob­al phar­ma gi­ant has been con­sid­er­ing a cor­po­rate re­struc­tur­ing